Emergent BioSolutions Inc (EBS)
9.35
+0.41
(+4.59%)
USD |
NYSE |
Oct 04, 16:00
9.30
-0.05
(-0.53%)
After-Hours: 20:00
Emergent BioSolutions Shareholders Equity (Annual): 649.30M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 649.30M |
| December 31, 2022 | 1.388B |
| December 31, 2021 | 1.612B |
| December 31, 2020 | 1.447B |
| December 31, 2019 | 1.088B |
| December 31, 2018 | 1.011B |
| December 31, 2017 | 912.30M |
| December 31, 2016 | 596.20M |
| December 31, 2015 | 660.02M |
| December 31, 2014 | 553.20M |
| December 31, 2013 | 489.62M |
| Date | Value |
|---|---|
| December 31, 2012 | 441.36M |
| December 31, 2011 | 414.25M |
| December 31, 2010 | 369.46M |
| December 31, 2009 | 241.20M |
| December 31, 2008 | 199.35M |
| December 31, 2007 | 171.16M |
| December 31, 2006 | 138.47M |
| December 31, 2005 | 59.74M |
| December 31, 2004 | 22.95M |
| December 31, 2002 | 4.155M |
| December 31, 2001 | -32.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
649.30M
Minimum
2023
1.612B
Maximum
2021
1.237B
Average
1.388B
Median
2022
Shareholders Equity (Annual) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 105.52M |
| Abbott Laboratories | 38.60B |
| SIGA Technologies Inc | 196.86M |
| Chimerix Inc | 193.03M |
| Co-Diagnostics Inc | 86.01M |